TenNor Therapeutics
Kenneth Chang is on the Board of Advisors at TenNor Therapeutics. Kenneth is also a Professor and Chief, Division of Gastroenterology and Executive Director of the H. H. Chao Comprehensive Digestive Disease Center, School of Medicine at the University of California in Irvine.
This person is not in the org chart
This person is not in any offices
TenNor Therapeutics
TenNor Therapeutics is a clinical-stage company with a sharp focus on discovery and development of differentiated products to address unmet medical needs in infectious disease area. The company possesses a novel multi-targeting drug conjugate platform and a globally protected new drug development portfolio.